Evidence map›Paper›PMID 41356376›Full record

ArticleWorld journal of stem cells2025

Role of human umbilical cord mesenchymal stem cells in diabetic kidney disease.

Yan Liu, Xiao-Qian Shan, Yu-Jiao Li, Wei-Li Gao, Lan Zhao

Abstract readLetter
PubMed Full text at PMC Publisher
In one paragraph

Article in World journal of stem cells, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Yan LiuFirst Teaching Hospital of Tianjin University of Traditional Chinese Medicine, Tianjin 300381, China.
Xiao-Qian ShanFirst Teaching Hospital of Tianjin University of Traditional Chinese Medicine, Tianjin 300381, China.
Yu-Jiao LiFirst Teaching Hospital of Tianjin University of Traditional Chinese Medicine, Tianjin 300381, China.
Wei-Li GaoFirst Teaching Hospital of Tianjin University of Traditional Chinese Medicine, Tianjin 300381, China.
Lan ZhaoFirst Teaching Hospital of Tianjin University of Traditional Chinese Medicine, Tianjin 300381, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

One of the most prevalent long-term effects of diabetes is diabetic kidney disease (DKD), which is linked to problems with the metabolism of amino acids, fats, and carbohydrates. The fundamental pathogenic mechanisms of DKD cannot be adequately treated by current clinical medicines; they can only slow the illness's progression to end-stage renal disease. We will concentrate on integrating human umbilical cord mesenchymal stem cell (hUC-MSC)-related mechanisms and potential applications into the therapy of DKD, as this work shows that hUC-MSCs can be used to treat metabolic liver obesity associated with diabetes. Future studies on the connection between hUC-MSCs and related illnesses ought to be promoted.

Indexed as

DiabetesDiabetic complicationsDiabetic kidney diseaseHuman umbilical cord mesenchymal stem cellsMetabolic dysfunction-associated steatotic liver diseaseMetabolic dysregulation

Identifiers

PMID41356376
PMCPMC12679249

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.